IM8
David Beckham is slinging supplements.
Game on. The former footballer’s wellness brand IM8 unveiled its first products this week. Co-developed with biotech company Prenetics, the lineup features all-in-one pills and powders for healthy aging.
Leveraging Beckham’s legacy, IM8’s daily drink mix is positioned as a longevity-focused competitor to AG1 — notably comparing the two brands head-to-head on its website.
Ageless. With influencer marketing and Prenetics’ clinical chops, plus a board of advisors from NASA, Mayo Clinic, and Cedars-Sinai, IM8 aims to crack an increasingly competitive category.
Just a few of many touting science-backed anti-aging protocols, Timeline raised $66M and Tally Health scored $10M, while upstarts NOVOS and Jung+ launched longevity care platforms.
Looking ahead: Star power sells, but a celeb endorsement doesn’t guarantee life-extending benefits. Navigating an underregulated industry, consumers are wise to tread lightly until results catch up to claims.
